Skip to main content

Therapy of Hypoparathyroidism and Vitamin D Deficiency

  • Chapter
Endocrine Replacement Therapy in Clinical Practice

Part of the book series: Contemporary Endocrinology ((COE))

  • 119 Accesses

Abstract

Calcium is a critically important mineral necessary for both intracellular and extra-cellular processes. Calcium circulates in the blood in an ionized state, bound to albumin and other serum proteins, and chelated to citrate, sulfate, and lactate. Only the free, ionized form of calcium is biologically active. Generally, total serum concentrations of calcium reflect the ionized calcium available to cells. However, there are two clinically important exceptions to this rule: (1) alkalosis will decrease ionized calcium concentration because of an increase in the binding of calcium ions to albumin and (2) in many chronic illnesses, substantial reductions in serum albumin concentrations occur, and this may lower total serum calcium concentrations while the ionized calcium concentration remains normal. The circulating level of ionized calcium is maintained in the physiologic range through the concerted actions of parathyroid hormone (PTH) and 1,25dihydroxyvitamin D, which mobilize calcium stores from bone and increase the efficiency of intestinal calcium absorption and renal calcium reabsorption. Hypocalcemia, in general, is an uncommon disorder. However, defects in the production or recognition of either PTH or 1,25-dihydroxyvitamin D, or a chronic deficiency of vitamin D, can precipitate hypocalcemia. Additionally, the removal of calcium from the circulation can occasionally exceed the capacity for correction by PTH and 1,25-dihydroxyvitamin D. In this section, the clinical presentations and appropriate therapeutic approaches for disorders associated with either deficient PTH or vitamin D action are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nusynowitz ML, Frame B, Kolb FO. The spectrum of hypoparathyroid states: A classification based on physiologic principles. Medicine 1976; 55: 105–119.

    Article  PubMed  CAS  Google Scholar 

  2. Winer KK, Yanovski JA, Cutler GB. Synthetic human parathyroid hormone 1–34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 1996; 276: 631–636.

    Google Scholar 

  3. Wozniewicz B, Migaj M, Giera B, et al. Cell culture preparation of human parathyroid cells for allotransplantation without immunosuppression. Trans Proc 1996; 28: 3542–3544.

    CAS  Google Scholar 

  4. Tolloczko T, Wozniewicz B, Sawicki A, et al. Clinical results of human cultured parathyroid cell allotransplantation in the treatment of surgical hypoparathyroidism. Trans Proc 1996; 28: 3545, 3546.

    Google Scholar 

  5. Avioli LV. The therapeutic approach to hypoparathyroidism. Am J Med 1974; 57: 34–42.

    Article  PubMed  CAS  Google Scholar 

  6. Okano K, Furukawa Y, Morii H, Fujita T. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism. J Clin Endocrinol Metab 1982; 55: 238–243.

    Article  PubMed  CAS  Google Scholar 

  7. Parfitt AM. The interactions of thiazide diuretics with parathyroid hormone and vitamin D J Clin Invest 1972; 51: 1879–1888.

    CAS  Google Scholar 

  8. Porter RH, Cox BG, Heaney D, et al. Treatment of hypoparathyroid patients with chlorthalidone. N Engl J Med 1978; 298: 577–581.

    Article  PubMed  CAS  Google Scholar 

  9. Drezner MK. Disorders of vitamin D metabolism: rickets and osteomalacia. In: Manolagos SC, Olefsky JM (eds.) Metabolic Bone and Mineral Disorders., vol. 5. Churchill Livingstone, New York, 1988, pp. 103–129.

    Google Scholar 

  10. Davies M, Adams PH. The continuing risk of vitamin D intoxication. Lancet 1978;i:621–623.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Orwoll, E.S. (2003). Therapy of Hypoparathyroidism and Vitamin D Deficiency. In: Meikle, A.W. (eds) Endocrine Replacement Therapy in Clinical Practice. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-375-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-375-0_5

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-416-6

  • Online ISBN: 978-1-59259-375-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics